Eric Aguiar's Net Worth
-$39.8 Million
Who is Eric Aguiar?
Eric Aguiar does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Invitae Corp, Biohaven Pharmaceutical Holding Co Ltd., BridgeBio Pharma, Inc., HEALTHCARE ACQUISITION CORP, REPLIDYNE INC, Eidos Therapeutics, Inc., Biomea Fusion, Inc., CRITICAL THERAPEUTICS INC, Ocera Therapeutics, Inc., ADVANCIS PHARMACEUTICAL CORP, and ACTIVBIOTICS INC.
SEC CIK
Eric Aguiar's CIK is 0001262325
Past Insider Trading and Trends
2019 was Eric Aguiar's most active year for acquiring shares with 14 total transactions. Eric Aguiar's most active month to acquire stocks was the month of March. 2020 was Eric Aguiar's most active year for disposing of shares, totalling 21 transactions. Eric Aguiar's most active month to dispose stocks was the month of December. 2019 saw Eric Aguiar paying a total of $56,097,235.92 for 2,173,804 shares, this is the most they've acquired in one year. In 2020 Eric Aguiar cashed out on 165,292 shares for a total of $4,051,419.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HEALTHCARE ACQUISITION CORP (ALT) Snapshot price: $10.376
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,537.74% | 3.17M |
$7.66 | $957,500.00 | 3.3M |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REPLIDYNE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +710.86% | 3.17M |
—
|
—
| 3.61M |
Jul 3
| |||
Form 4
| +1,069.02% | 3.17M |
—
|
—
| 3.46M |
Jul 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CRITICAL THERAPEUTICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 4.06M |
$7.00 | $2,499,700.00 | 4.06M |
Mar 5 - Jun 2
| |||
Form 4
|
∞
| 4.06M |
$7.00 | $2,499,700.00 | 4.06M |
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADVANCIS PHARMACEUTICAL CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.34% | 682.9K |
$2.36 | $1,614,177.82 | 6.22M |
Apr 12
| |||
Form 4
|
∞
| 5.53M |
—
|
—
| 5.53M |
Oct 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ACTIVBIOTICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,537.74% | 3.17M |
$7.66 | $957,500.00 | 3.3M |
Aug 3
| |||
| No matching records found | |||||||||